Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Dishman Pharmaceuticals And Chemicals Ltd Announces Appointment Of Chief Executive Officer


Wednesday, 3 Jul 2013 06:26am EDT 

Dishman Pharmaceuticals and Chemicals Ltd announced that Mr. Mark Griffiths has been appointed as CEO of Dishman Group of Companies, worldwide. 

Latest Developments forDishman Pharmaceuticals and Chemicals Ltd

Company Quote

128.85
-11.7 -8.32%
6:30am EDT